JP2023552790A5 - - Google Patents
Info
- Publication number
- JP2023552790A5 JP2023552790A5 JP2023534646A JP2023534646A JP2023552790A5 JP 2023552790 A5 JP2023552790 A5 JP 2023552790A5 JP 2023534646 A JP2023534646 A JP 2023534646A JP 2023534646 A JP2023534646 A JP 2023534646A JP 2023552790 A5 JP2023552790 A5 JP 2023552790A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyldiyl
- peg
- alkyl
- immunoconjugate according
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063124396P | 2020-12-11 | 2020-12-11 | |
| US63/124,396 | 2020-12-11 | ||
| PCT/US2021/062824 WO2022125908A1 (en) | 2020-12-11 | 2021-12-10 | Anti-pd-l1 immunoconjugates, and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023552790A JP2023552790A (ja) | 2023-12-19 |
| JP2023552790A5 true JP2023552790A5 (https=) | 2024-12-11 |
Family
ID=79288110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023534646A Pending JP2023552790A (ja) | 2020-12-11 | 2021-12-10 | 抗ｐｄ－ｌ１イムノコンジュゲート、及びそれらの使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240033370A1 (https=) |
| EP (1) | EP4259209A1 (https=) |
| JP (1) | JP2023552790A (https=) |
| KR (1) | KR20230118149A (https=) |
| CN (1) | CN116723866A (https=) |
| AU (1) | AU2021398552A1 (https=) |
| CA (1) | CA3200168A1 (https=) |
| IL (1) | IL303491A (https=) |
| WO (1) | WO2022125908A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024539993A (ja) * | 2021-10-29 | 2024-10-31 | ボルト バイオセラピューティクス、インコーポレーテッド | システイン変異抗体を含むｔｌｒアゴニスト免疫複合体、及びその使用 |
| WO2024173384A1 (en) | 2023-02-14 | 2024-08-22 | Bolt Biotherapeutics, Inc. | Aza-benzazepine immunoconjugates, and uses thereof |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3101690B2 (ja) | 1987-03-18 | 2000-10-23 | エス・ビィ・２・インコーポレイテッド | 変性抗体の、または変性抗体に関する改良 |
| JP2003531149A (ja) | 2000-04-13 | 2003-10-21 | ザ・ロツクフエラー・ユニバーシテイ | 抗体由来の免疫応答の増強 |
| DK1791565T3 (en) | 2004-09-23 | 2016-08-01 | Genentech Inc | Cysteingensplejsede antibodies and conjugates |
| WO2006073921A2 (en) | 2004-12-30 | 2006-07-13 | The Rockefeller University | Compositions and methods for enhanced dendritic cell maturation and function |
| US20080286819A1 (en) | 2005-11-07 | 2008-11-20 | Ravetch Jeffrey V | Reagents, Methods and Systems for Selecting a Cytotoxic Antibody or Variant Thereof |
| CL2008001334A1 (es) | 2007-05-08 | 2008-09-22 | Genentech Inc | Anticuerpo anti-muc16 disenado con cisteina; conjugado que lo comprende; metodo de produccion; formulacion farmaceutica que lo comprende; y su uso para tratar el cancer. |
| NZ584514A (en) | 2007-10-19 | 2012-07-27 | Genentech Inc | Cysteine engineered anti-tenb2 antibodies and antibody drug conjugates |
| US20120121615A1 (en) | 2010-11-17 | 2012-05-17 | Flygare John A | Alaninyl maytansinol antibody conjugates |
| BR112016014952A2 (pt) | 2014-02-10 | 2017-09-19 | Merck Patent Gmbh | Inibição direcionada de tgfbeta |
| AU2015349878A1 (en) | 2014-11-21 | 2017-05-25 | Bristol-Myers Squibb Company | Antibodies against CD73 and uses thereof |
| CN107344931B (zh) * | 2016-05-06 | 2020-09-15 | 上海迪诺医药科技有限公司 | 苯并氮杂卓衍生物、其制备方法、药物组合物及应用 |
| US20190336615A1 (en) * | 2017-01-27 | 2019-11-07 | Silverback Therapeutics, Inc. | Tumor targeting conjugates and methods of use thereof |
| MX2021002764A (es) * | 2018-09-12 | 2021-05-12 | Silverback Therapeutics Inc | Composiciones para el tratamiento de enfermedades con conjugados inmunoestimuladores. |
| JP7558205B2 (ja) * | 2019-06-13 | 2024-09-30 | ボルト バイオセラピューティクス、インコーポレーテッド | 高分子支持アミノベンズアピン化合物 |
| US20200390899A1 (en) * | 2019-06-13 | 2020-12-17 | Bolt Biotherapeutics, Inc. | Aminobenzazepine compounds, immunoconjugates, and uses thereof |
| US20230293716A1 (en) * | 2020-05-08 | 2023-09-21 | Bolt Biotherapeutics, Inc. | Elastase-substrate, peptide linker immunoconjugates, and uses thereof |
| US20220195066A1 (en) * | 2020-12-11 | 2022-06-23 | Bolt Biotherapeutics, Inc. | Anti-cea immunoconjugates, and uses thereof |
-
2021
- 2021-12-10 CA CA3200168A patent/CA3200168A1/en active Pending
- 2021-12-10 CN CN202180080177.5A patent/CN116723866A/zh active Pending
- 2021-12-10 WO PCT/US2021/062824 patent/WO2022125908A1/en not_active Ceased
- 2021-12-10 KR KR1020237022941A patent/KR20230118149A/ko active Pending
- 2021-12-10 JP JP2023534646A patent/JP2023552790A/ja active Pending
- 2021-12-10 US US18/038,910 patent/US20240033370A1/en active Pending
- 2021-12-10 IL IL303491A patent/IL303491A/en unknown
- 2021-12-10 AU AU2021398552A patent/AU2021398552A1/en active Pending
- 2021-12-10 EP EP21840291.5A patent/EP4259209A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022537158A5 (https=) | ||
| JP2022553702A5 (https=) | ||
| JP2023553421A5 (ja) | 抗ｃｅａ免疫複合体、及びその使用 | |
| JP2024523453A5 (https=) | ||
| JP2023524271A5 (https=) | ||
| JP2024059609A5 (https=) | ||
| JP7058666B2 (ja) | 抗体－薬物複合体化のための二置換マレインアミドリンカーならびにその調製方法および使用 | |
| JP2024521629A (ja) | 抗体薬物コンジュゲート、及びその調製方法及びその使用 | |
| JP2022549510A5 (https=) | ||
| JP2020019787A5 (https=) | ||
| JP2023552792A5 (https=) | ||
| JP2019532056A5 (https=) | ||
| JP2024533356A5 (https=) | ||
| JP2023552790A5 (https=) | ||
| CN104755106A (zh) | 药物-蛋白质缀合物 | |
| HRP20200032T1 (hr) | Antitijelo lijek konjugati | |
| JP2024511088A5 (https=) | ||
| JP2022554094A5 (https=) | ||
| JP2022546110A5 (https=) | ||
| JP2025510606A5 (https=) | ||
| JP2020531430A (ja) | 抗体を標的とする抗ｃｔｌａ４プロボディ療法 | |
| JP2022512401A5 (https=) | ||
| JP2024501453A5 (https=) | ||
| JP2023552791A5 (https=) | ||
| JP2025539841A5 (https=) |